Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders - PubMed (original) (raw)

Review

Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders

Michael G Aman et al. Child Adolesc Psychiatr Clin N Am. 2008 Oct.

Abstract

We reviewed the recent literature on medicines used to manage inattention, impulsiveness, and overactivity in children with pervasive developmental disorders (autistic disorder, pervasive developmental disorder not otherwise specified, Asperger's disorder) using computer searches of pharmacologic studies. A substantial number of reports were identified and summarized. The literature tends to be dominated by uncontrolled studies, although the number of controlled trials is growing. Findings are described for psychostimulants, noradrenergic reuptake inhibitors, antipsychotics, alpha adrenergic agonists, antidepressants, anxiolytics, cholinesterase inhibitors, N-methyl-D-aspartate receptor blockers, and antiepileptic mood stabilizers. Evidence for a positive effect is strongest for psychostimulants, noradrenergic reuptake inhibitors, antipsychotics, and alpha adrenergic agonists. Evidence for efficacy seems weakest for newer antidepressants, anxiolytics, and mood stabilizers.

PubMed Disclaimer

Cited by

Atomoxetine, Parent Training, and Their Effects on Sleep in Youth with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.
Hollway JA, Mendoza-Burcham M, Andridge R, Aman MG, Handen B, Arnold LE, Lecavalier L, Williams C, Silverman L, Smith T. Hollway JA, et al. J Child Adolesc Psychopharmacol. 2018 Mar;28(2):130-135. doi: 10.1089/cap.2017.0085. Epub 2017 Nov 7. J Child Adolesc Psychopharmacol. 2018. PMID: 29112459 Free PMC article. Clinical Trial.
Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study.
Lamberti M, Siracusano R, Italiano D, Alosi N, Cucinotta F, Di Rosa G, Germanò E, Spina E, Gagliano A. Lamberti M, et al. Paediatr Drugs. 2016 Aug;18(4):319-29. doi: 10.1007/s40272-016-0183-3. Paediatr Drugs. 2016. PMID: 27278054 Clinical Trial.
A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders.
Esbensen AJ, Greenberg JS, Seltzer MM, Aman MG. Esbensen AJ, et al. J Autism Dev Disord. 2009 Sep;39(9):1339-49. doi: 10.1007/s10803-009-0750-3. Epub 2009 May 12. J Autism Dev Disord. 2009. PMID: 19434487 Free PMC article.
The effect of stimulants on irritability in autism comorbid with ADHD: a systematic review.
Ghanizadeh A, Molla M, Olango GJ. Ghanizadeh A, et al. Neuropsychiatr Dis Treat. 2019 Jun 6;15:1547-1555. doi: 10.2147/NDT.S194022. eCollection 2019. Neuropsychiatr Dis Treat. 2019. PMID: 31239689 Free PMC article. Review.
Advances in understanding and treating ADHD.
Antshel KM, Hargrave TM, Simonescu M, Kaul P, Hendricks K, Faraone SV. Antshel KM, et al. BMC Med. 2011 Jun 10;9:72. doi: 10.1186/1741-7015-9-72. BMC Med. 2011. PMID: 21658285 Free PMC article. Review.

References

1. Lecavalier L. Behavioral and emotional problems in young people with pervasive developmental disorders: Relative prevalence, effects of subject characteristics, and empirical classification. J Autism Dev Disord. 2006;36:1101–14. - PubMed
1. Aman MG, Tassé MJ, Rojahn J, et al. The Nisonger CBRF: A child behavior rating form for children with developmental disabilities. Res Dev Disabil. 1996;17:41–57. - PubMed
1. Arnold LE, Gadow KD, Pearson DA, et al. Stimulants. In: Reiss S, Aman MG, editors. Psychotropic medication and developmental disabilities: The International Consensus Handbook. Columbus, OH: Ohio State University Nisonger Center; 1998. pp. 229–57.
1. Aman MG, Buican B, Arnold LE. Methylphenidate treatment in children with low IQ and ADHD: Analysis of three aggregated studies. J Child Adolesc Psychopharmacol. 2003;13:27–38. - PubMed
1. Pearson D, Lane D, Santos C, et al. Effects of methylphenidate treatment in children with mental retardation and ADHD: Individual variation in medication response. J Am Acad Child Adolesc Psychiatry. 2004;43:686–98. - PubMed

Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders - PubMed (original) (raw)